Literature DB >> 28339439

Dezocine Antagonizes Morphine Analgesia upon Simultaneous Administration in Rodent Models of Acute Nociception.

Na-Na Li1, Ya-Qin Huang2, Ling-Er Huang1, Shao-Hui Guo1, Maxwell R Shen1, Chen-Ling Guo1, Sheng-Mei Zhu1, Yong-Xing Yao1.   

Abstract

BACKGROUND: Dezocine is a powerful analgesic that can be less addictive than morphine, yet how the two drugs interact in vivo is poorly understood. Here we administered dezocine alone or in combination with morphine to different acute nociception paradigms to explore the interactions of the 2 drugs upon co-administration.
OBJECTIVE: To evaluate how dezocine interacts with morphine in different acute nociception paradigms. STUDY
DESIGN: Laboratory animal study.
SETTING: Zhejiang University School of Medicine, Hangzhou, China.
METHODS: Healthy mice were treated with saline, dezocine (0.625 - 2.5 µg), or a combination of dezocine with morphine (2.5 µg). Tail withdrawal latency (TWL) was analyzed prior to and 30 minutes after drug administration. Rats were treated with saline, morphine (3 mg/kg), dezocine (3 mg/kg), or a combination of both drugs. The animals were then left uninjured, subjected to plantar incision, or underwent formaldehyde-induced acute inflammation. Nociception was then analyzed in terms of mechanical threshold (MT) to von Frey stimulation and paw withdrawal latency (PWL) to thermal stimulation. Formaldehyde-induced pain score was calculated based on the duration of biting and elevating of the animal's legs. Phosphorylation of extracellular signal-regulated kinase (pERK) was also measured after plantar incision as a molecular index of nociception.
RESULTS: Dezocine enhanced TWL but inhibited morphine analgesia in a dose-dependent fashion in mice. Usage of morphine or dezocine alone in uninjured rats increased MT, but co-administering both drugs did not further increase MT. Usage of one drug alone, and both drugs together increased MT and PWL relative to saline at 30 minutes after incision. Usage of one drug alone, but not both drugs together, increased MT and PWL at 120 minutes after incision. Dezocine reduced formaldehyde-induced nociception but co-administering both drugs did not further reduce pain behavior. LIMITATIONS: The results were obtained from animal study; clinical investigations will be needed to clarify their interaction.
CONCLUSION: Dezocine antagonizes morphine analgesia on acute nociception upon simultaneous administration.Key words: Dezocine, morphine, acute nociception, analgesia.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28339439

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  10 in total

1.  Effects of Dezocine and Sufentanil on Th1/Th2 Balance in Breast Cancer Patients Undergoing Surgery.

Authors:  Xudong Hu; Bing Luo; Qing Wu; Qingbiao Chen; Penghui Lu; Jie Huang; Xiaoxia Liang; Cheng Ling; Yiqun Li
Journal:  Drug Des Devel Ther       Date:  2021-12-02       Impact factor: 4.162

Review 2.  Dezocine as a potent analgesic: overview of its pharmacological characterization.

Authors:  Rong-Rong Ye; Shuang Jiang; Xu Xu; Yan Lu; Yu-Jun Wang; Jing-Gen Liu
Journal:  Acta Pharmacol Sin       Date:  2021-11-04       Impact factor: 7.169

3.  Antinociceptive effects of dezocine on complete Freund's adjuvant-induced inflammatory pain in rats.

Authors:  Zhenhai Ye; Maoxian Zhang; Ning Ding; Peng Gao; Yunpeng Hei; Yun Wang; Wei Gao; Qingshan Ye
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

Review 4.  Comparison of the efficacy and safety between dezocine injection and morphine injection for persistence of pain in Chinese cancer patients: a meta-analysis.

Authors:  Lei Wang; Xudong Liu; Jianfeng Wang; Yingjiao Sun; Guozhuan Zhang; Lishuang Liang
Journal:  Biosci Rep       Date:  2017-06-08       Impact factor: 3.840

5.  Additive analgesic effect of dexmedetomidine and dezocine administered intrathecally in a mouse pain model.

Authors:  Ya-Qin Huang; Shao-Hui Guo; Renyu Liu; Sheng-Mei Zhu; Jian-Liang Sun; Yong-Xing Yao
Journal:  Oncotarget       Date:  2018-05-11

6.  Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist.

Authors:  Yu-Hua Wang; Jing-Rui Chai; Xue-Jun Xu; Ru-Feng Ye; Gui-Ying Zan; George Yun-Kun Liu; Jian-Dong Long; Yan Ma; Xiang Huang; Zhi-Chao Xiao; Hu Dong; Yu-Jun Wang
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

7.  Silencing of spinal Trpv1 attenuates neuropathic pain in rats by inhibiting CAMKII expression and ERK2 phosphorylation.

Authors:  Shao-Hui Guo; Jia-Piao Lin; Ling-Er Huang; Yan Yang; Chao-Qin Chen; Na-Na Li; Meng-Yun Su; Xian Zhao; Sheng-Mei Zhu; Yong-Xing Yao
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

8.  "I'll Be Back": The Resurrection of Dezocine.

Authors:  Wayne E Childers; Magid A Abou-Gharbia
Journal:  ACS Med Chem Lett       Date:  2021-05-19       Impact factor: 4.632

9.  Dexmedetomidine Attenuates Neuropathic Pain by Inhibiting P2X7R Expression and ERK Phosphorylation in Rats.

Authors:  Jia-Piao Lin; Chao-Qin Chen; Ling-Er Huang; Na-Na Li; Yan Yang; Sheng-Mei Zhu; Yong-Xing Yao
Journal:  Exp Neurobiol       Date:  2018-08-30       Impact factor: 3.261

10.  Interaction of Analgesic Effects of Dezocine and Sufentanil for Relief of Postoperative Pain: A Pilot Study.

Authors:  He Zhu; Yaobing Chen; Shaoqiang Huang; Xingfeng Sun
Journal:  Drug Des Devel Ther       Date:  2020-11-03       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.